DNA
Ginkgo Bioworks Holdings, Inc. · Healthcare · Market cap $636.5M
Insiders sold $1.4M net in the last 90 days ·5 sellers, 0 buyers· 1 of 7 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 21, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.0M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Oct 21, 2026
Shetty Reshma P.
Ginkgo Bioworks Holdings, Inc. (DNA) has 19 SEC Form 4 filings (61 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Oct 21, 2026.
Inside the rolling window, 5 insiders at Ginkgo Bioworks Holdings, Inc. reported no open-market purchases and 22 open-market sales totaling $5.0M. The most active filer is See remarks Coen Steven P. with 10 filings. Insiders have net sold $1.4M over the trailing 6 months. The most recent open-market filing is a sale of 41,172 shares by See remarks Shetty Reshma P., dated Oct 19, 2026, worth $418K.
- Industry:Biotechnology
- CEO:Jason Kelly
- Employees:485
- HQ:Boston, MA, US
- IPO:2021-04-19
| Source | |||||||
|---|---|---|---|---|---|---|---|
Shetty Reshma P.First in 6 months | See remarks | Sale | 41,172 | $418K | Oct 21 | -0.2% | SEC ↗ |
Canton BarryFirst in 6 months | 10% Owner | Sale | 41,172 | $418K | Oct 21 | -0.2% | SEC ↗ |
| See remarks | Sale | 766 | $8K | Oct 21 | -0.2% | SEC ↗ | |
Kelly Jason RFirst in 6 months | See remarks | Sale | 45,682 | $463K | Oct 21 | -0.2% | SEC ↗ |
| See remarks | Sale | 2,403 | $36K | Oct 7 | -12.9% | SEC ↗ | |
HENRY CHRISTIAN OFirst in 7 months | Director | Sale | 5,000 | $35K | Sep 16 | +41.5% | SEC ↗ |
| See remarks | Sale | 330 | $2K | Aug 25 | +32.5% | SEC ↗ | |
| See remarks | Sale | 752 | $6K | Jul 20 | +32.3% | SEC ↗ | |
| See remarks | Sale | 307 | $3K | May 26 | — | SEC ↗ | |
| See remarks | Sale | 324 | $3K | Apr 20 | — | SEC ↗ | |
| See remarks | Sale | 33,171 | $213K | Apr 14 | — | SEC ↗ | |
| See remarks | Sale | 124,727 | $802K | Apr 13 | — | SEC ↗ | |
| 10% Owner | Sale | 124,727 | $802K | Apr 13 | — | SEC ↗ | |
Kelly Jason RFirst filing | See remarks | Sale | 97,015 | $672K | Apr 10 | — | SEC ↗ |
Kelly Jason RFirst filing | See remarks | Sale | 109,767 | $702K | Apr 10 | — | SEC ↗ |
Canton BarryFirst filing | 10% Owner | Sale | 13,155 | $91K | Apr 10 | — | SEC ↗ |
Canton BarryFirst filing | 10% Owner | Sale | 13,116 | $84K | Apr 10 | — | SEC ↗ |
Shetty Reshma P.First filing | See remarks | Sale | 13,155 | $91K | Apr 10 | — | SEC ↗ |
Shetty Reshma P.First filing | See remarks | Sale | 13,116 | $84K | Apr 10 | — | SEC ↗ |
| See remarks | Sale | 708 | $5K | Mar 18 | — | SEC ↗ | |
| See remarks | Sale | 972 | $9K | Jan 22 | — | SEC ↗ | |
Coen Steven P.First filing | See remarks | Sale | 736 | $7K | Dec 16 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does DNA have?
Ginkgo Bioworks Holdings, Inc. (DNA) has 19 SEC Form 4 filings (61 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Oct 21, 2026.
When was the most recent SEC Form 4 filing for DNA?
The most recent Form 4 filing for DNA on Tracefour is dated Oct 21, 2026.
Who is the most active insider at DNA?
The most active SEC Form 4 filer at DNA in the rolling window is See remarks Coen Steven P., with 10 filings.
What is the net insider flow at DNA over the last 6 months?
Over the trailing 180 days, insiders at DNA have net sold $1.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at DNA in the current window?
Inside the rolling window, insiders at DNA bought $0 and sold $5.0M based on SEC Form 4 filings.
Can I get alerts for DNA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Ginkgo Bioworks Holdings, Inc. (DNA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Ginkgo Bioworks Holdings, Inc. is in the Healthcare sector.